Circassia Pharmaceuticals (CIRL)

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 284.89m
  • Volume: 0

CIRL Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

Chief Finance Officer: Michael R D Roller
Chief Operating Officer: Jonathan Emms
Executive Chairman: Ian Johnson
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Sharon Curran
Senior Independent Director: Garry Watts
Non-Executive Dir: Nicholas Mills, Robert (Rob) Graham Naylor

Contact Details

Address: Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4GB
Phone: +44 (0)1865 405560
Fax: +44 (0)7092 987560
Website: http://www.niox.com/

Listings

Overseas Listings: LSE:NIOX
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

CIRL Market Data

Currency UK Pounds
Share Price 0.000p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 284.89m

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 5
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page